| Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights P Marmiroli, B Riva, E Pozzi, E Ballarini, D Lim, A Chiorazzi, C Meregalli, ... PloS one 12 (10), e0186250, 2017 | 66 | 2017 |
| A novel gain‐of‐function mutation in ORAI1 causes late‐onset tubular aggregate myopathy and congenital miosis M Garibaldi, F Fattori, B Riva, C Labasse, G Brochier, P Ottaviani, ... Clinical genetics 91 (5), 780-786, 2017 | 55 | 2017 |
| Pyrtriazoles, a novel class of store-operated calcium entry modulators: discovery, biological profiling, and in vivo proof-of-concept efficacy in acute pancreatitis B Riva, A Griglio, M Serafini, C Cordero-Sanchez, S Aprile, R Di Paola, ... Journal of medicinal chemistry 61 (21), 9756-9783, 2018 | 30 | 2018 |
| Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors A Potenzieri, B Riva, R Rigolio, A Chiorazzi, E Pozzi, E Ballarini, ... Pain 161 (2), 405-415, 2020 | 24 | 2020 |
| Oxaliplatin induces pH acidification in dorsal root ganglia neurons B Riva, M Dionisi, A Potenzieri, A Chiorazzi, C Cordero-Sanchez, ... Scientific Reports 8 (1), 15084, 2018 | 23 | 2018 |
| A luminal EF-hand mutation in STIM1 in mice causes the clinical hallmarks of tubular aggregate myopathy C Cordero-Sanchez, B Riva, S Reano, N Clemente, I Zaggia, FA Ruffinatti, ... Disease Models & Mechanisms 13 (2), dmm041111, 2020 | 22 | 2020 |
| Calcium-related neurotoxicity of oxaliplatin: understanding the mechanisms to drive therapy P Marmiroli, G Cavaletti, V Carozzi, B Riva, D Lim, A A Genazzani Current medicinal chemistry 22 (32), 3682-3694, 2015 | 20 | 2015 |
| Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2 B Riva, M De Dominici, I Gnemmi, SA Mariani, A Minassi, V Minieri, ... Oncotarget 7 (49), 81555, 2016 | 19 | 2016 |
| Store-operated calcium entry as a therapeutic target in acute pancreatitis: discovery and development of drug-like SOCE inhibitors M Serafini, C Cordero-Sanchez, R Di Paola, IP Bhela, S Aprile, B Purghè, ... Journal of Medicinal Chemistry 63 (23), 14761-14779, 2020 | 16 | 2020 |
| Expanding the clinical and genetic spectrum of pathogenic variants in STIM1 C Ticci, D Cassandrini, A Rubegni, B Riva, G Vattemi, S Matà, G Ricci, ... Muscle & Nerve 64 (5), 567-575, 2021 | 9 | 2021 |
| SiO2 nanoparticles modulate the electrical activity of neuroendocrine cells without exerting genomic effects C Distasi, FA Ruffinatti, M Dionisi, S Antoniotti, A Gilardino, G Croci, ... SCIeNTIFIC REPORtS 8 (1), 2760, 2018 | 9 | 2018 |
| STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca2+-entry modulators CIC-37 and CIC-39 B Riva, E Pessolano, E Quaglia, C Cordero-Sanchez, IP Bhela, A Topf, ... Cell Calcium 105, 102605, 2022 | 7 | 2022 |
| CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy C Cordero-Sanchez, E Pessolano, B Riva, M Vismara, SMG Trivigno, ... Blood advances 6 (15), 4471-4484, 2022 | 6 | 2022 |
| 1, 2, 4-Oxadiazole-Bearing pyrazoles as metabolically stable modulators of store-operated calcium entry S Aprile, B Riva, IP Bhela, C Cordero-Sanchez, G Avino, AA Genazzani, ... ACS Medicinal Chemistry Letters 12 (4), 640-646, 2021 | 6 | 2021 |
| Unexpected Ca2+-mobilization of oxaliplatin via H1 histamine receptors A Potenzieri, B Riva, AA Genazzani Cell Calcium 86, 102128, 2020 | 6 | 2020 |
| Modulators of SOCE, compositions and use thereof T Pirali, B Riva, AA Genazzani WO Patent WO212 414, 2017 | 5 | 2017 |
| Dissecting the mechanism of action of spiperone—a candidate for drug repurposing for colorectal cancer A Antona, M Varalda, K Roy, F Favero, E Mazzucco, M Zuccala, G Leo, ... Cancers 14 (3), 776, 2022 | 4 | 2022 |
| Characterization of a functional Ca2+ toolkit in urine-derived stem cells and derived skeletal muscle cells M Talmon, E Massara, G Pruonto, M Quaregna, F Boccafoschi, B Riva, ... Cell Calcium 103, 102548, 2022 | 3 | 2022 |
| Early stimulation of TREK channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification M Dionisi, FA Ruffinatti, B Riva, D Lim, A Canta, C Meregalli, G Fumagalli, ... International Journal of Molecular Sciences 21 (19), 7164, 2020 | 3 | 2020 |
| Bitter taste receptor (TAS2R) 46 in human skeletal muscle: expression and activity M Talmon, E Massara, M Quaregna, M De Battisti, F Boccafoschi, ... Frontiers in Pharmacology 14, 1205651, 2023 | 2 | 2023 |
